Subject(s)

Alanine Transaminase/blood , Aspartate Aminotransferases/blood , Betacoronavirus , Chemical and Drug Induced Liver Injury , Chloroquine , Coronavirus Infections , Hepatitis, Viral, Human , Lopinavir , Pandemics , Pneumonia, Viral , Ritonavir , Antiviral Agents/administration & dosage , Antiviral Agents/adverse effects , Betacoronavirus/isolation & purification , Betacoronavirus/pathogenicity , COVID-19 , COVID-19 Testing , Chemical and Drug Induced Liver Injury/blood , Chemical and Drug Induced Liver Injury/diagnosis , Chemical and Drug Induced Liver Injury/etiology , Chloroquine/administration & dosage , Chloroquine/adverse effects , Clinical Laboratory Techniques/methods , Coronavirus Infections/complications , Coronavirus Infections/diagnosis , Coronavirus Infections/drug therapy , Coronavirus Infections/physiopathology , Diagnosis, Differential , Drug Combinations , Hepatitis, Viral, Human/blood , Hepatitis, Viral, Human/diagnosis , Hepatitis, Viral, Human/etiology , Humans , Liver/pathology , Liver Function Tests/methods , Lopinavir/administration & dosage , Lopinavir/adverse effects , Male , Middle Aged , Pneumonia, Viral/complications , Pneumonia, Viral/diagnosis , Pneumonia, Viral/physiopathology , Ritonavir/administration & dosage , Ritonavir/adverse effects , SARS-CoV-2 , COVID-19 Drug Treatment